Search research articles
Contact Us
Filters
Showing results (61-70 of 89) with videos related to
Page
of 9
Sort By:
Journal of Hematology & Oncology
|
December 1, 2020
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
Tracy C Kuo, Amy Chen, Ons Harrabi, et al.
Mabs
|
July 2, 2019
Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα
Janet Sim, Jonathan T Sockolosky, Emma Sangalang, et al.
The Journal of Biological Chemistry
|
April 30, 2016
Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain
Anatoly Shcherbatko, Andrea Rossi, Davide Foletti, et al.
Nature Communications
|
January 30, 2021
Direct control of CAR T cells through small molecule-regulated antibodies
Spencer Park, Edward Pascua, Kevin C Lindquist, et al.
Journal of Molecular Biology
|
July 27, 2011
Synthetic antibodies designed on natural sequence landscapes
Wenwu Zhai, Jacob Glanville, Markus Fuhrmann, et al.
Bioinformatics (Oxford, England)
|
October 25, 2012
A method for integrative structure determination of protein-protein complexes
Dina Schneidman-Duhovny, Andrea Rossi, Agustin Avila-Sakar, et al.
Nature Communications
|
November 19, 2016
Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire
Yik Andy Yeung, Davide Foletti, Xiaodi Deng, et al.
Molecular Cancer Therapeutics
|
September 2, 2016
RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models
Pavel Strop, Thomas-Toan Tran, Magdalena Dorywalska, et al.
Journal of Molecular Biology
|
December 27, 2011
Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease
Sherry L La Porte, Sangeetha Subbarao Bollini, Thomas A Lanz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 25, 2011
Proprotein convertase substilisin/kexin type 9 antagonism reduces low-density lipoprotein cholesterol in statin-treated hypercholesterolemic nonhuman primates
Hong Liang, Javier Chaparro-Riggers, Pavel Strop, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 89) with videos related to
Sort By:
Page
of 9
Journal of Hematology & Oncology
|
December 1, 2020
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
Tracy C Kuo, Amy Chen, Ons Harrabi, et al.
Mabs
|
July 2, 2019
Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα
Janet Sim, Jonathan T Sockolosky, Emma Sangalang, et al.
The Journal of Biological Chemistry
|
April 30, 2016
Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain
Anatoly Shcherbatko, Andrea Rossi, Davide Foletti, et al.
Nature Communications
|
January 30, 2021
Direct control of CAR T cells through small molecule-regulated antibodies
Spencer Park, Edward Pascua, Kevin C Lindquist, et al.
Journal of Molecular Biology
|
July 27, 2011
Synthetic antibodies designed on natural sequence landscapes
Wenwu Zhai, Jacob Glanville, Markus Fuhrmann, et al.
Bioinformatics (Oxford, England)
|
October 25, 2012
A method for integrative structure determination of protein-protein complexes
Dina Schneidman-Duhovny, Andrea Rossi, Agustin Avila-Sakar, et al.
Nature Communications
|
November 19, 2016
Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire
Yik Andy Yeung, Davide Foletti, Xiaodi Deng, et al.
Molecular Cancer Therapeutics
|
September 2, 2016
RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models
Pavel Strop, Thomas-Toan Tran, Magdalena Dorywalska, et al.
Journal of Molecular Biology
|
December 27, 2011
Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease
Sherry L La Porte, Sangeetha Subbarao Bollini, Thomas A Lanz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 25, 2011
Proprotein convertase substilisin/kexin type 9 antagonism reduces low-density lipoprotein cholesterol in statin-treated hypercholesterolemic nonhuman primates
Hong Liang, Javier Chaparro-Riggers, Pavel Strop, et al.
Page
of 9